Research ArticleDrug Discovery and Translational Medicine
Pharmacological Characterization of a Novel Beta 3 Adrenergic Agonist, Vibegron: Evaluation of Antimuscarinic Receptor Selectivity for Combination Therapy for Overactive Bladder
J. Di Salvo, H. Nagabukuro, L. A. Wickham, C. Abbadie, J. A. DeMartino, A. Fitzmaurice, L. Gichuru, A. Kulick, M. J. Donnelly, N. Jochnowitz, A. L. Hurley, A. Pereira, A. Sanfiz, G. Veronin, K. Villa, J. Woods, B. Zamlynny, E. Zycband, G.M. Salituro, T. Frenkl, A. E. Weber, S. D. Edmondson and M. Struthers
Journal of Pharmacology and Experimental Therapeutics February 2017, 360 (2) 346-355; DOI: https://doi.org/10.1124/jpet.116.237313
J. Di Salvo
Discovery and Preclinical Sciences, Merck Research Laboratories, Kenilworth, New Jersey
H. Nagabukuro
Discovery and Preclinical Sciences, Merck Research Laboratories, Kenilworth, New Jersey
L. A. Wickham
Discovery and Preclinical Sciences, Merck Research Laboratories, Kenilworth, New Jersey
C. Abbadie
Discovery and Preclinical Sciences, Merck Research Laboratories, Kenilworth, New Jersey
J. A. DeMartino
Discovery and Preclinical Sciences, Merck Research Laboratories, Kenilworth, New Jersey
A. Fitzmaurice
Discovery and Preclinical Sciences, Merck Research Laboratories, Kenilworth, New Jersey
L. Gichuru
Discovery and Preclinical Sciences, Merck Research Laboratories, Kenilworth, New Jersey
A. Kulick
Discovery and Preclinical Sciences, Merck Research Laboratories, Kenilworth, New Jersey
M. J. Donnelly
Discovery and Preclinical Sciences, Merck Research Laboratories, Kenilworth, New Jersey
N. Jochnowitz
Discovery and Preclinical Sciences, Merck Research Laboratories, Kenilworth, New Jersey
A. L. Hurley
Discovery and Preclinical Sciences, Merck Research Laboratories, Kenilworth, New Jersey
A. Pereira
Discovery and Preclinical Sciences, Merck Research Laboratories, Kenilworth, New Jersey
A. Sanfiz
Discovery and Preclinical Sciences, Merck Research Laboratories, Kenilworth, New Jersey
G. Veronin
Discovery and Preclinical Sciences, Merck Research Laboratories, Kenilworth, New Jersey
K. Villa
Discovery and Preclinical Sciences, Merck Research Laboratories, Kenilworth, New Jersey
J. Woods
Discovery and Preclinical Sciences, Merck Research Laboratories, Kenilworth, New Jersey
B. Zamlynny
Discovery and Preclinical Sciences, Merck Research Laboratories, Kenilworth, New Jersey
E. Zycband
Discovery and Preclinical Sciences, Merck Research Laboratories, Kenilworth, New Jersey
G.M. Salituro
Discovery and Preclinical Sciences, Merck Research Laboratories, Kenilworth, New Jersey
T. Frenkl
Discovery and Preclinical Sciences, Merck Research Laboratories, Kenilworth, New Jersey
A. E. Weber
Discovery and Preclinical Sciences, Merck Research Laboratories, Kenilworth, New Jersey
S. D. Edmondson
Discovery and Preclinical Sciences, Merck Research Laboratories, Kenilworth, New Jersey
M. Struthers
Discovery and Preclinical Sciences, Merck Research Laboratories, Kenilworth, New Jersey
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleDrug Discovery and Translational Medicine
Pharmacological Characterization of Vibegron
J. Di Salvo, H. Nagabukuro, L. A. Wickham, C. Abbadie, J. A. DeMartino, A. Fitzmaurice, L. Gichuru, A. Kulick, M. J. Donnelly, N. Jochnowitz, A. L. Hurley, A. Pereira, A. Sanfiz, G. Veronin, K. Villa, J. Woods, B. Zamlynny, E. Zycband, G.M. Salituro, T. Frenkl, A. E. Weber, S. D. Edmondson and M. Struthers
Journal of Pharmacology and Experimental Therapeutics February 1, 2017, 360 (2) 346-355; DOI: https://doi.org/10.1124/jpet.116.237313
Research ArticleDrug Discovery and Translational Medicine
Pharmacological Characterization of Vibegron
J. Di Salvo, H. Nagabukuro, L. A. Wickham, C. Abbadie, J. A. DeMartino, A. Fitzmaurice, L. Gichuru, A. Kulick, M. J. Donnelly, N. Jochnowitz, A. L. Hurley, A. Pereira, A. Sanfiz, G. Veronin, K. Villa, J. Woods, B. Zamlynny, E. Zycband, G.M. Salituro, T. Frenkl, A. E. Weber, S. D. Edmondson and M. Struthers
Journal of Pharmacology and Experimental Therapeutics February 1, 2017, 360 (2) 346-355; DOI: https://doi.org/10.1124/jpet.116.237313
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement